Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 10, 2014 - Issue 8
Submit an article Journal homepage
667
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Understanding the pharmacogenetics of selective serotonin reuptake inhibitors

Chiara FabbriUniversity of Bologna, Institute of Psychiatry, Department of Biomedical and NeuroMotor Sciences, Viale Carlo Pepoli 5, 40123 Bologna, Italy+39 051 6584233; +39 051 521030; [email protected]
,
Alessandro MinariniUniversity of Bologna, Institute of Psychiatry, Department of Biomedical and NeuroMotor Sciences, Viale Carlo Pepoli 5, 40123 Bologna, Italy+39 051 6584233; +39 051 521030; [email protected]
,
Tomihisa NiitsuUniversity of Bologna, Institute of Psychiatry, Department of Biomedical and NeuroMotor Sciences, Viale Carlo Pepoli 5, 40123 Bologna, Italy+39 051 6584233; +39 051 521030; [email protected];Chiba University Graduate School of Medicine, Research Center for Child Mental Development, Chiba, Japan
&
Alessandro SerrettiUniversity of Bologna, Institute of Psychiatry, Department of Biomedical and NeuroMotor Sciences, Viale Carlo Pepoli 5, 40123 Bologna, Italy+39 051 6584233; +39 051 521030; [email protected]
, MD PhD
Pages 1093-1118 | Published online: 14 Jun 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kristina Probst-Schendzielorz, Roberto Viviani & Julia C Stingl. (2015) Effect of Cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors. Expert Opinion on Drug Metabolism & Toxicology 11:8, pages 1219-1232.
Read now

Articles from other publishers (12)

M. A. Novitsky, A. De Sousa, A. R. Asadullin, O. A. Gavrilyuk, A. V. Petrov & R. F. Nasyrova. (2021) Possibilities and limitations of antidepressant use to correct depressive and negative symptoms in schizophrenia. Personalized Psychiatry and Neurology 1:2, pages 21-45.
Crossref
David W. Oslin, Sara Chapman, Scott L. Duvall, Joel Gelernter, Erin P. Ingram, Henry R. Kranzler, Lisa Soleymani Lehmann, Julie A. Lynch, Kevin G. Lynch, Jeff M. Pyne, Mei-Chiung Shih, Annjanette Stone, Michael E. Thase & Laura O. Wray. (2021) Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial. Contemporary Clinical Trials 101, pages 106247.
Crossref
Joanna M. Biernacka, Ahmed T. Ahmed, Balwinder Singh & Mark A. Frye. 2020. Personalized Psychiatry. Personalized Psychiatry 403 412 .
Leland E Hull, Catherine Chanfreau-Coffinier, Sony Tuteja, Dan Berlowitz, Lisa S Lehmann, David W Oslin, Jeffrey M Pyne, Scott L DuVall & Julie A Lynch. (2019) Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications. Pharmacogenomics 20:11, pages 781-789.
Crossref
Yi Liu, Jingping Zhao & Wenbin Guo. (2018) Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders. Frontiers in Psychology 9.
Crossref
Aizati N A Daud, Jorieke E H Bergman, Wilhelmina S Kerstjens-Frederikse, Pieter van der Vlies, Eelko Hak, Rolf M F Berger, Henk Groen & Bob Wilffert. (2017) Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study. Pharmacogenomics 18:10, pages 987-1001.
Crossref
M Gupta, D Neavin, D Liu, J Biernacka, D Hall-Flavin, W V Bobo, M A Frye, M Skime, G D Jenkins, A Batzler, K Kalari, W Matson, S S Bhasin, H Zhu, T Mushiroda, Y Nakamura, M Kubo, L Wang, R Kaddurah-Daouk & R M Weinshilboum. (2016) TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. Molecular Psychiatry 21:12, pages 1717-1725.
Crossref
Tanja DujicKaixin ZhouRoger TavendaleColin N.A. PalmerEwan R. Pearson. (2016) Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study. Diabetes Care 39:11, pages 1896-1901.
Crossref
Allan V. Kalueff, Adam Michael Stewart, Michael Nguyen, Cai Song & Irving I. Gottesman. (2015) Targeting drug sensitivity predictors: New potential strategies to improve pharmacotherapy of human brain disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 63, pages 76-82.
Crossref
Antonio M. Persico, Celso Arango, Jan K. Buitelaar, Christoph U. Correll, Jeffrey C. Glennon, Pieter J. Hoekstra, Carmen Moreno, Benedetto Vitiello, Jacob Vorstman & Alessandro Zuddas. (2015) Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives. European Neuropsychopharmacology 25:10, pages 1513-1531.
Crossref
Chiara Fabbri & Alessandro Serretti. (2015) Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications. Current Psychiatry Reports 17:7.
Crossref
Daniela Caldirola & Giampaolo Perna. (2015) Is there a role for pharmacogenetics in the treatment of panic disorder?. Pharmacogenomics 16:8, pages 771-774.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.